Clinical trial
A Phase 3, 12-Month, Extension Study to Evaluate the Safety of Asoprisnil in Subjects With Uterine Leiomyomata
NCT00156195 is registered in ClinicalTrials.gov with Abbott as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 3, 12-Month, Extension Study to Evaluate the Safety of Asoprisnil in Subjects With Uterine Leiomyomata
- Lead sponsor
- Abbott
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- September 30, 2003
- Completion date
- January 31, 2007
- Enrollment
- 523 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.